DD298411A5 - Therapeutische peptide - Google Patents

Therapeutische peptide Download PDF

Info

Publication number
DD298411A5
DD298411A5 DD90343501A DD34350190A DD298411A5 DD 298411 A5 DD298411 A5 DD 298411A5 DD 90343501 A DD90343501 A DD 90343501A DD 34350190 A DD34350190 A DD 34350190A DD 298411 A5 DD298411 A5 DD 298411A5
Authority
DD
German Democratic Republic
Prior art keywords
phe
amino acid
deleted
pro
trp
Prior art date
Application number
DD90343501A
Other languages
German (de)
English (en)
Inventor
David H Coy
Jacques-Pierre Moreau
Original Assignee
��������@��@����������@��@��@����������@���������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��@����������@��@��@����������@���������k�� filed Critical ��������@��@����������@��@��@����������@���������k��
Publication of DD298411A5 publication Critical patent/DD298411A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD90343501A 1989-08-16 1990-08-16 Therapeutische peptide DD298411A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39472789A 1989-08-16 1989-08-16

Publications (1)

Publication Number Publication Date
DD298411A5 true DD298411A5 (de) 1992-02-20

Family

ID=23560172

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343501A DD298411A5 (de) 1989-08-16 1990-08-16 Therapeutische peptide

Country Status (15)

Country Link
EP (1) EP0438566B1 (el)
JP (1) JPH04502922A (el)
AT (1) ATE143372T1 (el)
CA (1) CA2039175A1 (el)
CZ (2) CZ285562B6 (el)
DD (1) DD298411A5 (el)
DE (1) DE69028692T2 (el)
DK (1) DK0438566T3 (el)
ES (1) ES2094160T3 (el)
GR (1) GR900100613A (el)
HU (1) HUT65465A (el)
IE (1) IE77033B1 (el)
PT (1) PT95016B (el)
SK (1) SK280796B6 (el)
WO (1) WO1991002745A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
FR2680174A1 (fr) * 1991-08-05 1993-02-12 Michelot Robert Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles.
PT533280E (pt) 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
CA2225185A1 (en) * 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
WO2008090117A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
JP5707101B2 (ja) * 2009-11-11 2015-04-22 国立大学法人山口大学 消化器疾患治療剤
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
AR128311A1 (es) * 2022-01-21 2024-04-17 Inst Pasteur De Montevideo Inmunización activa para reducir el dolor osteoarticular, neuropático y en cáncer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) * 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists

Also Published As

Publication number Publication date
JPH04502922A (ja) 1992-05-28
DE69028692D1 (de) 1996-10-31
DK0438566T3 (da) 1996-11-11
PT95016B (pt) 1997-05-28
EP0438566B1 (en) 1996-09-25
ATE143372T1 (de) 1996-10-15
ES2094160T3 (es) 1997-01-16
CZ402890A3 (cs) 1999-04-14
IE77033B1 (en) 1997-11-19
IE902958A1 (en) 1991-02-27
GR900100613A (el) 1991-12-30
EP0438566A4 (en) 1993-03-31
HU906872D0 (en) 1991-07-29
PT95016A (pt) 1991-04-18
DE69028692T2 (de) 1997-02-20
EP0438566A1 (en) 1991-07-31
WO1991002745A1 (en) 1991-03-07
CZ285562B6 (cs) 1999-09-15
SK402890A3 (en) 2000-07-11
HUT65465A (en) 1994-06-28
CZ285319B6 (cs) 1999-07-14
CA2039175A1 (en) 1991-02-17
SK280796B6 (sk) 2000-07-11

Similar Documents

Publication Publication Date Title
DE3852086T2 (de) Therapeutische Peptide.
DE69434181T2 (de) Therapeutische Peptidderivate
DE69027533T2 (de) Heilmittelpeptide
DE69734157T2 (de) Parathyroidhormon-verwandthe peptidanaloge
DE69722651T2 (de) Heptapeptid oxytocin analogen
DE68928667T2 (de) Peptide als arzneimittel
DE69129226T2 (de) Glp-1-analoga verwendbar in der diabetesbehandlung
DE69630233T2 (de) Zielgerichtete, zytotoxische anthracyclin-analoge
DE69534852T2 (de) Verbesserte zyclische crf agonisten
US5410019A (en) Therapeutic peptides
DE69015671T2 (de) Peptide und deren Benützung in der Therapie.
DD298411A5 (de) Therapeutische peptide
DE69725850T2 (de) Analoge des parathormons zur behandlung der osteoporose
EP0552238A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69723448T2 (de) Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität
DE69932255T2 (de) Hgh-rh(1-29)nh2 analoge mit antagonistischer aktivität gegen igf-i und -ii
DE2616647A1 (de) Peptidamidderivate und mittel, in denen sie enthalten sind
WO1993015109A2 (de) Parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
DE69531366T2 (de) Antagonisten des neuromedin b rezeptors
DE68921665T2 (de) Hemmer vom flüssigen kalziumerhöhenden Faktor.
DE69003172T2 (de) Synthetische Peptid-Antagonisten von Neurokinin A, deren Salze und respektive Herstellungsverfahren.
DE69938548T2 (de) Pth2 rezeptor selektive verbindungen
DE68912376T2 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
DE69420361T2 (de) Zyklische Hexapeptide mit Endothelin antagonistischer Aktivität
DE69119409T2 (de) Vasoaktive derivate des vasotocins

Legal Events

Date Code Title Description
EP Request for examination under paragraph 12(1) filed
WP12 As result of examination under paragraph 12 erstrg. patent revoked